follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeAuthorsAnkit Singhania

      Articles by Ankit Singhania

      Ankit Singhania
      Based in India, Ankit is a financial content writer and stock market analyst. He has worked for almost a decade on several financial projects related to the stock market news, fundamental research and technical analysis for several websites. He obtained his Masters Degree In finance (MS – finance) from ICFAI. Currently, he serves as a financial consultant and technical analyst at Tradersinsights.com.
      PHAS stock
      Biotechnology

      PHAS Stock Rockets 25% on Collaboration With SFJ Pharma

      Jan 10 Ankit Singhania
      In a development that would come as a major boost to PHAS stock, PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS) announced that it has reached a major agreement with SFJ Pharmaceuticals. Important Collaboration The company announced today that ... [Read]
      BBBY stock
      Retail

      BBBY Stock Slumps 18% on Surprise Q3 Loss, Withdraws 2019 Outlook

      Jan 9 Ankit Singhania
      BBBY stock is one of the biggest losers on Thursday after retail major Bed Bath & Beyond Inc. (NASDAQ:BBBY) revealed its earnings for the third quarter, which proved to be a disappointment. Moreover, the company ... [Read]
      PIXY stock
      Business Services

      PIXY Stock Rockets 165% as ShiftPixy Completes Recapitalization

      Jan 8 Ankit Singhania
      When it comes to companies in the service sector, nothing is a bigger boost than the signing of a new lucrative contract, so it’s no surprise that PIXY stock is soaring today after ShiftPixy Inc ... [Read]
      Else Nutrition
      Market Movers

      Stock Analysis: Else Nutrition Holdings Inc (TSX.V:BABY) (OTCQB:BABYF)

      Jan 7 Ankit Singhania
      Five Key Investment Highlights about Else Nutrition Holdings Inc. (TSX.V:BABY) (OTCQB:BABYF) Else Nutrition Holdings Inc. (TSX.V:BABY) (OTCQB:BABYF) has developed a breakthrough, science-backed product that is the first 100% plant-based, non-dairy, non-soy infant formula. Else Nutrition ... [Read]
      XERS stock
      Biotechnology

      XERS Stock Jumps 12% Following Positive RTU Glucagon Data

      Jan 7 Ankit Singhania
      When a pharmaceutical company announces positive results from any stage of a clinical study, then it almost always has a positive effect on the company’s stock. That is what happened with XERS stock in the ... [Read]
      PLUG stock
      Industrial Products

      PLUG Stock Jumps 14% After Announcing $172 Million Order

      Jan 6 Ankit Singhania
      PLUG stock is gaining momentum this morning after Plug Power Inc (NASDAQ:PLUG) received an order at the close of 2019 from a Fortune 100 customer for hydrogen fuel cell deployments. Investors Cheer the News One ... [Read]
      LPTX stock
      Biotechnology

      LPTX Stock Soars 60% After a Licensing Deal With BeiGene

      Jan 3 Ankit Singhania
      Licensing agreements are generally great news for pharmaceutical companies, which is why such a development almost always proves to be a positive for the stock price. That is what happened with LPTX stock this morning ... [Read]
      PULM stock
      Biotechnology

      PULM Stock Skyrockets 86% on Licensing Deal With Johnson & Johnson

      Jan 2 Ankit Singhania
      When a relatively small company ends up striking a deal with a giant corporation, then it generally proves to be a major boost for the stock. That is what has happened this morning with lightly ... [Read]
      SDRL stock
      Oil & Gas

      SDRL Stock Soars 16% on Multiple Contract Extensions in Middle East

      Dec 31 Ankit Singhania
      Over the course of 2019, SDRL stock has had a bit of a rollercoaster ride, but it is finishing the year strongly. The stock is down by as much as 70% this year, but in ... [Read]
      GPRO stock
      Computer Hardware

      GPRO Stock Disappoints This Year: Will It Rebound in 2020?

      Dec 30 Ankit Singhania
      GoPro Inc (NASDAQ:GPRO), the action camera manufacturer, has had a pretty tough time over the past few years. GPRO stock plunged by as much as 95% since 2014 and is currently a penny stock. That ... [Read]

      Posts pagination

      « 1 … 8 9 10 … 27 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE PhaseBio Pharmaceuticals Email Alerts
      Get FREE PhaseBio Pharmaceuticals Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x